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In 50 healthy Peruvian shantytown residents, zinc 
cream applied to tuberculosis skin-test sites caused a 32% 
increase in induration compared with placebo cream. Per-
sons with lower plasma zinc had smaller skin-test reactions 
and greater augmentation with zinc cream. Zinc defi ciency 
caused false-negative skin-test results, and topical zinc 
supplementation augmented antimycobacterial immune re-
sponses enough to improve diagnosis. 
Tuberculosis (TB) kills >1.7 million people each year, and control is hampered by diagnostic diffi culties. The 
TB (Mantoux) skin test measures the immune response to 
an intradermal injection of tuberculin (purifi ed protein de-
rivative [PPD]) and is important for diagnosing adult and 
particularly pediatric TB (1). However, reliability of this 
skin test is limited by false-negative results (2–4), espe-
cially in poorly nourished people in the resource-limited 
settings where most cases of TB occur (2). Zinc is impli-
cated in false-negative skin tests because it modulates cu-
taneous reactions (2,3), because zinc defi ciency is common 
in people with TB (5), and because this defi ciency also 
suppresses antimycobacterial immunity (4,5). We there-
fore studied whether topical application of zinc to TB skin 
test sites would augment test results in Lima, Peru, a TB-
endemic area in which false-negative skin-test results are 
frequent (1).
The Study
After ethical approval and informed written con-
sent were obtained, venous blood was collected from 50 
healthy, randomly selected, adult shantytown resident vol-
unteers. Plasma zinc concentrations were analyzed blindly 
by atomic absorption spectroscopy; precautions were taken 
against trace-metal contamination. In each study partici-
pant, the volar surface of both forearms was injected proxi-
mally with tuberculin (5 U in 0.1 mL; Aventis-Pasteur, To-
ronto, Canada) and distally with Candida albicans antigen 
(5 U; Hollister Stier Laboratories, Spokane, WA, USA) (1), 
totaling 4 simultaneous skin tests per person. Candida skin 
tests were conducted because, when positive, they confi rm 
that the person can mount a cutaneous hypersensitivity 
reaction, which clarifi es that a simultaneous negative TB 
skin-test result is likely to be a true negative.
In a randomized double-blind manner, skin-test sites 
on 1 arm were covered with 1 mL of placebo cream (Aque-
ous cream BP, Sandoz, Bordon, Hants, UK) and the skin-
test sites on the contralateral arm were covered with zinc 
sulfate (2) dissolved in aqueous cream to a concentration 
of 1% elemental zinc. Each skin test site was immediately 
covered with an occlusive dressing (Tegaderm, 3M, Lon-
don, UK). After 24, 48, and 72 h, the dressing and cream 
were removed, and the “ball-point-pen” test was used to 
measure induration. The appropriate cream was reapplied 
and covered after each measurement.
SPSS version 11.5 (SPSS Inc., Chicago, IL, USA) was 
used for statistical analysis. Except where otherwise stated, 
the results of skin tests are those read after 48 h. Continuous 
data were all normally distributed (except for food frequen-
cies) and were therefore summarized as means (and stan-
dard errors of the mean [SEM]). Groups were compared by 
using t tests, and associations were tested by using univari-
ate linear regression (p value and standardized coeffi cient 
shown) and in a backward multiple linear regression model 
with the least signifi cant variables sequentially removed, 
according to the log-likelihood test.
Conclusions
Control TB skin-test areas to which placebo cream had 
been applied yielded signifi cantly smaller reactions in per-
sons with lower concentrations of plasma zinc (p = 0.03, 
Table). For example, the quarter of the population with the 
lowest concentrations had, on average, control TB skin-test 
reactions that were 14 mm in diameter compared with 27 
mm for the quarter of the population with the highest plas-
ma zinc concentrations (p = 0.03). This immunologically 
signifi cant zinc defi ciency was frequent even though only 
10% of the study population was underweight (body mass 
index <20 m2/kg).
The TB skin-test results were read in a blinded manner, 
and reactions to tests with zinc cream applications were an 
average of 32% larger than the contralateral control skin test 
reactions with placebo cream applied (Figure 1; p<0.001). 
TB skin-test results were considered positive if the average 
diameter of induration was >10 mm 48 h after injection, 
according to national policy. Skin tests with zinc applica-
tions were signifi cantly more likely to have positive results 
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than the simultaneous contralateral control skin tests with 
placebo cream applications (94% zinc vs. 76% placebo, p 
= 0.01). Topical zinc caused greater TB skin-test augmen-
tation in persons with lower plasma zinc concentrations 
(correlation coeffi cient [R] = 0.3, p = 0.05), and persons 
with absolute plasma zinc defi ciency (<0.6 mg/L) had sig-
nifi cantly greater zinc-mediated augmentation (Figure 2, p 
= 0.02). Zinc cream had no effect in persons with normal 
plasma zinc concentrations. Thus, zinc cream signifi cantly 
augmented TB skin-test reactions only in persons defi cient 
in zinc (Figure 2).
TB skin tests are usually read 48 h after PPD injection; 
however, in this study, additional readings were done at 
24 and 72 h, at which time results, similar to those at 48 
h, demonstrated that zinc cream caused larger TB skin-test 
reactions (both p<0.02) and more positive test results (both 
p<0.006). Furthermore, at 72 and 48 h, this zinc-mediated 
augmentation was greater in zinc-defi cient persons (p = 
0.006), although the similar trend at 24 h was not statisti-
cally signifi cant. The magnitude of skin-test augmentation 
with zinc cream, the plasma zinc concentration, and the an-
thropometric measures had no signifi cant associations with 
other studied factors except as noted in the Table.
The effect of zinc on the Candida skin-test results 
was similar to the effect on the TB skin-test results. Spe-
cifi cally, the Candida skin-test reactions with zinc cream 
were an average of 23% larger than the contralateral skin-
test reactions associated with placebo cream applied in a 
double-blind manner (p<0.001). Candida skin-test results 
were considered positive if the average diameter of indura-
tion was >5 mm (1), and 78% of Candida skin-test results 
associated with zinc application were positive, compared 
with 64% with placebo cream (p = 0.01). Zinc-mediated 
TB and Candida skin-test augmentation were associated (R 
= 0.3, p = 0.05), but zinc-mediated Candida skin-test aug-
mentation was not signifi cantly associated with any of the 
variables in the Table.
The control skin tests with placebo cream yielded larg-
er reactions (p = 0.005) and were more likely to be positive 
(p = 0.005) than concurrent skin tests on 97 other randomly 
Table. Population characteristics for the participants who had simultaneous skin tests with and without zinc and associations with size 
of tuberculosis (TB) skin-test reaction 
Association with size of control TB skin-test reaction (mm)
Univariate analysis Multiple regression
Characteristic*
Mean (SEM)† or % 
(n = 50) Coefficient p Coefficient p
Nutritional assessment‡§
 Body mass index (kg/m2) 24 (0.52) 
10% underweight (<20)
0.2 0.3
 Anthropometric protein status 
 (corrected arm muscle area; cm2)
36 (1.4) 0.2 0.09
 Anthropometric fat status 
 (arm fat area; cm2)
14 (1.1) 0.0008 1
 Plasma zinc (mg/L; n = 49) 0.66 (0.17) 
31% deficient (<0.6)
0.3 0.04 0.3 0.03
Minor incidental health symptoms 38% 0.06 0.7
TB risk factors
 Age, y 32 (1.3) 0.2 0.2 0.3 0.02
 Male 38% 0.3 0.03 0.4 0.01
 Past close contact with a TB patient or  
 past proven diagnosis of TB 
42% 0.1 0.4
 Presence of Baccilus Calmette-Guérin  
 vaccine scar(s)
86% 0.2 0.3
 Overcrowding (persons/room) 1.3 (0.08) –0.2 0.9 0.2 0.09
 Poor household ventilation (subjective 
 assessment)
24% –0.002 1
Socioeconomic status
 Food spending/person/d ($US) 0.75 (0.05) 0.1 0.5
 Dirt floor throughout the home 38% –0.06 0.7
 Home built from temporary materials 72% 0.1 0.5
 No in-house sanitation 84% 0.05 0.7
 No piped water to home 84% –0.07 0.6
*Variables that may influence TB skin-test reaction size are shown together with their associations with the size of the control TB skin-test reactions 
associated with only zinc cream application. 
†SEM, standard error of the mean. 
‡Food frequencies: in the previous week, alcohol had been consumed a median of 1 time (median 1 U), dairy produce 3 times, fruit/vegetables 5 times, 
meat/fish 6 times, and rice/bread/cereals daily. 
§Persons with infrequent meat/fish consumption had lower protein stores on muscle anthropometry (p = 0.02), and this tended to be associated with 
smaller skin-test reactions, as previously reported (1,2). 
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selected healthy volunteers in the same community (data 
not shown). These 97 skin tests were each performed on 1 
arm only, and no creams were applied; the mean diameter 
of induration was 16.4 mm (SEM 1.9 mm), and 52% were 
TB skin-test positive (>10 mm). Although the design of this 
part of the study prevented blinded assessment, this com-
parison implies that in the 50 persons with simultaneous 
bilateral skin tests, zinc absorption through the skin may 
have partially augmented the contralateral control skin-test 
reactions to which placebo cream was applied. Although 
the local direct effect at the site of zinc cream application 
was signifi cantly greater, systemic zinc absorption may 
have caused the effect of zinc cream to be underestimated; 
this hypothesis is being further investigated.
Zinc status is diffi cult to reliably assess (2–4). How-
ever, low plasma zinc signifi cantly predicted small skin-
test reactions and the magnitude of the immunologic re-
sponse to topical supplementation. Thus, zinc cream had a 
specifi c effect, namely, reversing the skin-test suppression 
of zinc defi ciency. Topical zinc supplementation applied 
to the arms of persons who received TB skin tests there-
fore identifi ed persons in whom zinc defi ciency was suffi -
cient to suppress antimycobacterial immune responses and 
quantifi ed the immune-potentiating effect of supplementa-
tion. This approach may similarly facilitate the therapeutic 
evaluation of other micronutrients and immunomodulatory 
compounds.
Zinc cream had no effect in persons with adequate con-
centrations of zinc; however, persons who were defi cient in 
zinc but otherwise apparently healthy had suppressed skin-
test reactions, despite the absence of frank malnutrition; this 
suppression was reversed by the application of zinc cream. 
Thus, zinc cream application corrected false-negative TB 
skin-test reactions caused by zinc defi ciency, allowed more 
sensitive diagnosis, and hence facilitated appropriate treat-
ment of latent TB infection. Topical zinc is a simple and 
relatively inexpensive method of enhancing reliability of 
the established TB skin test for diagnosing this neglected 
disease. This has public health implications because the TB 
skin test is central to the problematic area of diagnosing 
TB infection and disease, especially in children who are 
prone to both zinc defi ciency (2,4) and false-negative skin-
test results (1). Therefore, the zinc-mediated augmentation 
of TB skin testing that we have demonstrated may facilitate 
the diagnosis of adult and pediatric cases of TB in regions 
where micronutrient defi ciency is prevalent. 
In conclusion, this study demonstrated that physiologi-
cally signifi cant subclinical zinc defi ciency was common 
in this population, that low plasma zinc predicted negative 
TB skin-test results, and that topical zinc supplementation 
augmented local antimycobacterial immune responses suf-
fi ciently to reverse this anergy of micronutrient defi ciency.
Figure 1. Effect of topical zinc on size of tuberculosis (TB) skin-
test reaction. Each line represents the size of the 2 TB skin-test 
reactions for 1 person with placebo cream (on the left of the graph) 
and topical zinc cream (on the right). Circles show the mean TB 
skin-test reaction size without and with topical zinc, with standard 
error bars.
Figure 2. Association between plasma zinc concentration and 
response to topical zinc. The association is shown between plasma 
zinc concentration and the magnitude of augmentation of the 
purifi ed protein derivative skin test with topical zinc. The normal 
range of plasma zinc (>0.6 mg/L) is also indicated.
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